🇺🇸 FDA
Patent

US 12156877

Methods of treating conditions related to a thiamine deficiency, a thiamine-dependent enzyme, or an associated cofactor

granted A61KA61K31/4415A61K31/51

Quick answer

US patent 12156877 (Methods of treating conditions related to a thiamine deficiency, a thiamine-dependent enzyme, or an associated cofactor) held by The Regents of the University of California expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4415, A61K31/51